Skip to main content
0
Introduction
Aim
Methods
Results
Conclusions
References
Disclosures
Slide deck
Aim
To assess the influence of DMARDs and/or glucocorticoids at baseline on the effect of nintedanib in the INBUILD trial.
×
Notice
This website is intended for healthcare professionals only.
Modal title
You are navigating away from the website. Are you sure you want to proceed?
